Published in Ann Surg on July 01, 1983
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Surgical management of portal hypertension. West J Med (1995) 0.95
Coagulopathy of Liver Disease. Curr Treat Options Gastroenterol (2000) 0.86
Fibrinolytic activity of ascites caused by alcoholic cirrhosis and peritoneal malignancy. Gut (1993) 0.81
Coagulopathy post peritoneovenous shunt. Ann Surg (1987) 0.79
Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer Patients. J Vasc Interv Radiol (2016) 0.75
Peritoneovenous shunting in intractable ascites. Ulster Med J (1985) 0.75
Peritoneo-venous shunting for ascites. Ann Surg (1974) 2.87
The Limulus coagulation test for endotoxin. A comparison with other assay methods. Proc Soc Exp Biol Med (1969) 1.92
Further experience with peritoneo-venous shunt for ascites. Ann Surg (1976) 1.92
Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis (1978) 1.61
Coagulation defects. JAMA (1961) 1.33
Complications after peritoneovenous shunting for ascites. Am J Surg (1980) 1.26
Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease. Alcohol Clin Exp Res (1982) 1.22
[Coagulation disorders during continuous reinjections of ascitic fluid. Fibrinolysis or intravascular coagulation?]. Nouv Presse Med (1973) 1.19
Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med (1982) 1.05
Effect of peritoneovenous shunting with the Le Veen valve on ascites, renal function, and coagulation in six patients with intractable ascites. Surgery (1978) 1.03
Disseminated intravascular coagulation with the peritoneovenous shunt. Ann Intern Med (1979) 1.03
Treatment of intractable ascites in patients with alcoholic cirrhosis by peritoneovenous shunting (LeVeen). Med Clin North Am (1979) 1.01
Hepatorenal syndrome: reversal by peritoneovenous shunt. Surgery (1977) 0.93
Disseminated intravascular coagulation. Complication of LeVeen peritoneovenous shunts. JAMA (1978) 0.89
Analysis of Twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen. Ann Surg (1980) 0.89
Coagulopathy following peritoneovenous shunting. Surgery (1979) 0.88
Fatal disseminated intravascular coagulation after peritoneovenous shunt for intractable ascites. Mayo Clin Proc (1978) 0.87
Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. Arch Intern Med (1981) 0.87
Palliation of malignant ascites by the LeVeen peritoneo-venous shunt. Cancer (1980) 0.82
Procoagulant activity of ascitic fluid in hepatic cirrhosis: in vivo and in vitro. Surgery (1979) 0.81
Peritoneovenous shunt and bacterial endotoxin. Mayo Clin Proc (1979) 0.80
Severe coagulopathy following insertion of the LeVeen shunt: a potentially fatal complication. Can J Surg (1979) 0.79
Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis (1989) 6.49
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med (1988) 5.92
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet (2000) 5.80
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIV. COMPARATIVE STUDIES ON THE NUTRITIVE VALUE OF ORALLY AND INTRAVENOUSLY ADMINISTERED HUMAN SERUM ALBUMIN IN MAN. J Clin Invest (1948) 5.08
A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA (1994) 4.85
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Hiccups: causes and cures. J Clin Gastroenterol (1985) 3.25
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA (1989) 2.73
Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology (1984) 2.72
An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med (1999) 2.56
Pattern formation by lateral inhibition with feedback: a mathematical model of delta-notch intercellular signalling. J Theor Biol (1996) 2.45
Spatial localization of the K+ channel selectivity filter by mutant cycle-based structure analysis. Neuron (1996) 2.38
Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med (1983) 2.36
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J Infect Dis (1994) 2.26
The antigenic relationship of alcohol-soluble substances of corpus luteum to those of testis and brain. Am J Pathol (1941) 2.15
A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol (1990) 2.13
The use of thromboelastography for the peripartum management of a patient with platelet storage pool disorder. Int J Obstet Anesth (2010) 2.04
Liver transplantation in hemophilia A. Blood (1987) 1.98
Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA (1989) 1.96
Intestinal obstruction due to bezoars. Am J Gastroenterol (1984) 1.83
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology (1990) 1.77
Positional information in chick limb morphogenesis. Nature (1973) 1.76
Blood use in liver transplantation. Transfusion (1987) 1.63
Organ transplantation in HIV-positive patients with hemophilia. N Engl J Med (1990) 1.52
Asymptomatic structural liver disease in hemophilia. N Engl J Med (1978) 1.50
A new system for defining endoscopic complications emphasizing the measure of importance. Gastrointest Endosc (1997) 1.48
Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Does the finger count? Arch Intern Med (1991) 1.42
Hepatitis C testing. Comparison of Ortho's EIA and RIBA II tests in 1,182 patients undergoing primary liver transplantation. Am J Clin Pathol (1992) 1.42
THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT, IN HEMOPHILIA, OF THE PARENTERAL ADMINISTRATION OF A FRACTION OF THE PLASMA GLOBULINS RICH IN FIBRINOGEN. J Clin Invest (1945) 1.41
Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology (1987) 1.39
DEANTIGENATED BEEF BLOOD PLASMA AS A POSSIBLE SUBSTITUTE FOR HUMAN BLOOD PLASMA. Science (1943) 1.39
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washington State. JAMA (1999) 1.38
Meckel's diverticulum: pitfalls in scintigraphic detection in the adult. Am J Gastroenterol (1984) 1.33
Liver transplantation in a hemophiliac. N Engl J Med (1985) 1.32
Genetic Considerations in Familial Hemorrhagic Disease. I. The Sex-Linked Recessive Disorders, Hemophilia and PTC Deficiency. Am J Hum Genet (1963) 1.27
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant (2006) 1.26
Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease. Blood (1978) 1.26
Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost (1980) 1.26
Purpura in congenital and acquired rubella. N Engl J Med (1965) 1.25
Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease. Alcohol Clin Exp Res (1982) 1.22
Mechanisms of inward-rectifier K+ channel inhibition by tertiapin-Q. Biochemistry (1999) 1.22
Hyaluronan as a propellant for epithelial movement: the development of semicircular canals in the inner ear of Xenopus. Development (1991) 1.20
Acquired immunodeficiency syndrome in the child of a haemophiliac. Lancet (1985) 1.20
Acquired-immunodeficiency-like syndrome in two haemophiliacs. Lancet (1983) 1.16
Factor VII deficiency. Am J Hematol (1981) 1.15
Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study. Am J Hematol (1993) 1.14
Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood (1985) 1.13
Pulmonary embolism in sickle cell disease: a case-control study. J Thromb Haemost (2012) 1.12
Listeria monocytogenes sepsis and small cell carcinoma of the rectum: an unusual presentation of the acquired immunodeficiency syndrome. Am J Clin Pathol (1985) 1.10
Lymphoma presenting as a traumatic hematoma in an HTLV-III antibody-positive hemophiliac. N Engl J Med (1985) 1.09
High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: implications for colon cancer screening. Gastroenterology (1996) 1.09
Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations. Transfusion (1986) 1.07
Enflurane hepatotoxicity. A clinicopathologic study of 24 cases. Ann Intern Med (1983) 1.06
Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med (1987) 1.06
Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation (1989) 1.06
Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf. J Clin Invest (1986) 1.05
Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology (1992) 1.04
Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial. J Infect Dis (1995) 1.04
Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity. Gastroenterology (1988) 1.03
Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation (1989) 1.02
A study of liver biopsies and liver disease among hemophiliacs. Blood (1985) 1.00
Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen. J Infect Dis (1982) 1.00
Australin antigen detection. Comparison of results obtained with five CEP and one RIA test systems. Transfusion (1972) 0.99
Fate maps and the pattern of cell division: a calculation for the chick wing-bud. J Embryol Exp Morphol (1975) 0.97
Steroid-induced pancreatitis: does it really exist? Gastroenterology (1981) 0.96
Measuring the incremental cost of clinical cancer research. J Clin Oncol (2001) 0.95
Successful treatment of homozygous protein C deficiency by hepatic transplantation. Lancet (1988) 0.95
Hemophilia, hepatitis and HAA. Vox Sang (1971) 0.95
DiC-like syndrome after envenomation by the snake, Crotalus horridus horridus. N Engl J Med (1975) 0.95